Trial reportClinical journal of the American Society of Nephrology : CJASN2011
A nurse-coordinated model of care versus usual care for stage 3/4 chronic kidney disease in the community: a randomized controlled trial.
Trial report in Clinical journal of the American Society of Nephrology : CJASN, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 38 papers, 6 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Telemonitoring to Improve Outcomes of Patients With Chronic Kidney Disease
Effectiveness of Integrated Care on Delaying Chronic Kidney Disease Progression in Rural Communities of Thailand (ESCORT Study)
Who cites it
38 citing papers in PubMed, 6 syntheses or guidelines pooled it, 108 citations in OpenAlex.
- Effectiveness of Multicomponent Interventions in Slowing Progression of CKD Stages G3-G4: A Systematic Review and Meta-Analysis.Clinical journal of the American Society of Nephrology : CJASN · 2026Pooled it
- Effects of multidisciplinary teamwork in non-hospital settings on healthcare and patients with chronic conditions: a systematic review and meta-analysis.BMC primary care · 2025Pooled it
- Improving Blood Pressure Management in Primary Care Patients with Chronic Kidney Disease: a Systematic Review of Interventions and Implementation Strategies.Journal of general internal medicine · 2020Pooled it
- Effectiveness of self-management support interventions for people with comorbid diabetes and chronic kidney disease: a systematic review and meta-analysis.Systematic reviews · 2018Pooled it
- The effectiveness of multidisciplinary care models for patients with chronic kidney disease: a systematic review and meta-analysis.International urology and nephrology · 2018Pooled it
- Pooled it
- Impact of superimposed nephrological care to guidelines-directed management by primary care physicians of patients with stable chronic kidney disease: a randomized controlled trial.BMC nephrology · 2020Trial
- Effectiveness of Integrated Care on Delaying Progression of stage 3-4 Chronic Kidney Disease in Rural Communities of Thailand (ESCORT study): a cluster randomized controlled trial.BMC nephrology · 2017Trial
- Using pharmacists to improve risk stratification and management of stage 3A chronic kidney disease: a feasibility study.BMC nephrology · 2016Trial
- A pharmacist based intervention to improve the care of patients with CKD: a pragmatic, randomized, controlled trial.BMC nephrology · 2015Trial
- Effectiveness of integrated care on delaying chronic kidney disease progression in rural communities of Thailand (ESCORT study): rationale and design of the study [NCT01978951].BMC nephrology · 2014Trial
- Nurse practitioner care improves renal outcome in patients with CKD.Journal of the American Society of Nephrology : JASN · 2014Trial
- Effect of shared care on blood pressure in patients with chronic kidney disease: a cluster randomised controlled trial.The British journal of general practice : the journal of the Royal College of General Practitioners · 2013Trial
- Cost-effectiveness analysis of a randomized trial comparing care models for chronic kidney disease.Clinical journal of the American Society of Nephrology : CJASN · 2011Trial
- The impact of nurse-led care in chronic kidney disease management: a systematic review and meta-analysis.BMC nursing · 2025Article
- Clinical Outcomes of a Novel Multidisciplinary Care Program in Advanced Kidney Disease (PEAK).Kidney international reports · 2024Article
- Economic Evaluation of an Integrated Care Program Compared to Conventional Care for Patients With Chronic Kidney Disease in Rural Communities of Thailand.Kidney international reports · 2024Article
- Nurse Practitioner Care Compared with Primary Care or Nephrologist Care in Early CKD.Clinical journal of the American Society of Nephrology : CJASN · 2023Article
- Effectiveness and current status of multidisciplinary care for patients with chronic kidney disease in Japan: a nationwide multicenter cohort study.Clinical and experimental nephrology · 2023Observational
- The Effect of Medical Cooperation in the CKD Patients: 10-Year Multicenter Cohort Study.Journal of personalized medicine · 2023Article
Corrections and comments
- Commented on by
Authors and funding
11 authors at 9 institutions in 1 country.
Funding
Abstract
BACKGROUND AND
objectivesIt is unclear how to optimally care for chronic kidney disease (CKD). This study compares a new coordinated model to usual care for CKD. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: A randomized trial in nephrology clinics and the community included 474 patients with median estimated GFR (eGFR) 42 ml/min per 1.73 m(2) identified by laboratory-based case finding compared care coordinated by a general practitioner (controls) with care by a nurse-coordinated team including a nephrologist (intervention) for a median (interquartile range [IQR]) of 742 days. 32% were diabetic, 60% had cardiovascular disease, and proteinuria was minimal. Guided by protocols, the intervention team targeted risk factors for adverse kidney and cardiovascular outcomes. Serial eGFR and clinical events were tracked.
resultsThe average decline in eGFR over 20 months was -1.9 ml/min per 1.73 m(2). eGFR declined by ≥4 ml/min per 1.73 m(2) within 20 months in 28 (17%) intervention patients versus 23 (13.9%) control patients. Control of BP, LDL, and diabetes were comparable across groups. In the intervention group there was a trend to greater use of renin-angiotensin blockers and more use of statins in those with initial LDL >2.5 mmol/L. Treatment was rarely required for anemia, acidosis, or disordered mineral metabolism. Clinical events occurred in 5.2% per year.
conclusionsPatients with stage 3/4 CKD identified through community laboratories largely had nonprogressive kidney disease but had cardiovascular risk. Over a median of 24 months, the nurse-coordinated team did not affect rate of GFR decline or control of most risk factors compared with usual care.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.